NanoPass Technologies
Intradermal Delivery Solutions
Startup C Health Tech & Life Sciences Est. 2000
Total Raised
$14.1M
C
Last Round
$6M
6 rounds
Investors
6
6 public
Team
5
11-50 employees
Confidence
92/100
News
14
articles
Patents
1
About
NanoPass is where cutting-edge technology intersects with healthcare innovation. We pioneer revolutionary solutions in intradermal delivery, reshaping the landscape of therapeutic and medical aesthetic procedures using our proprietary technology towards a precise, safe, and efficient future. Our MicronJetTM intradermal delivery product platform has redefined the standard of care. Join us on our journey as we pave the way for a healthier, brighter future.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentDrug DeliveryMedical DevicesMedical Treatment & Therapeutics
Core Technology
Materials & SubstancesSilicon
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProviders
Business Model
B2B
Tags
cosmeticsmedical-equipmentdiabetespharma-companiesdrug-deliverymedical-technologiespain-freedoctorshospitalshealthcare-providersvaccinesnanotechnology
Funding & Events
May 2019
C Round Undisclosed
Jul 2024
Undisclosed Round $6M
Awz Ventures
Jul 2012
B Round Undisclosed
Israel HealthCare Ventures (IHCV)
Feb 2007
A Round $6.5M
WFD Ventures LLC, Ofer Hi-Tech, Undisclosed Investor(s)
Apr 2016
Undisclosed Round Undisclosed
West Pharmaceutical Services
Apr 2000
Seed $1.6M
Ofer Hi-Tech
News (14)
Aug 4, 2024 · www.nanopass.com
Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device
Jul 14, 2024 · www.prnewswire.com
growth-positive
NanoPass Technologies Secures Awz Ventures' $4M Investment, Signaling Growth and Innovation in Intradermal Delivery Technology
InvestmentManagement Changes
Feb 20, 2022 · www.globes.co.il
growth-positive
ננופס תחל בניסוי במוצר שעשוי לשפר את יעילות חיסוני הקורונה
InvestmentPartners
Feb 7, 2022 · www.prnewswire.com
growth-positive
NanoPass's intradermal injection platform proven to sustain COVID-19 vaccine antibodies using 1/15 of the dose reports Chinese Institute of Medical Biology
Partners
Jan 2, 2022 · techtime.co.il
growth-positive
ננו-פאס פיתחה את המחט הרפואית הזעירה בעולם - Techtime - חדשות אלקטרוניקה והייטק
Partners
Apr 25, 2016 · www.prnewswire.com
growth-positive
West Makes Investment in NanoPass Technologies
Investment
Sep 8, 2015 · www.prnewswire.com
growth-positive
NanoPass Technologies to Supply MicronJet600™ Device to Immune Design for Use in ZVex-based Oncology Immunotherapy Products
Partners
May 6, 2015 · www.prnewswire.com
growth-positive
NanoPass Technologies Grants an Exclusive License to Circassia Pharmaceuticals, for use of its MicronJet600™ Device in Allergy Testing in the US
Partners
Nov 29, 2012 · www.prnewswire.com
growth-positive
NanoPass Technologies Grants a Commercial License to Janssen Pharmaceuticals, Inc., for use of its MicronJet Device
Partners
Jul 31, 2012 · en.globes.co.il
growth-positive
Skin delivery solutions co NanoPass raises several million dollars
Investment
Sep 15, 2011 · pipelinereview.com
growth-positive
The Biologics News and Reports Portal
Partners
Aug 31, 2009 · www.idri.org
https://www.idri.org/idri-use-nanopass-micorneedle-technology/
Feb 26, 2007 · www.nanooze.org
growth-positive
Hate Needles? Now NanoPass needles offer painless vaccinations...
Customers
Feb 14, 2007 · en.globes.co.il
growth-positive
Intradermal drug delivery co NanoPass raises $6.5m
Investment
Details
Product Stage
Released
Employees
11-50
Exact Count
21
District
Center District
Founded
2000
Registrar
512936212
Crunchbase
nanopass-technologies
Locations
Golda Me'ir St 3, Ness Ziona, Israel
Links
Website
LinkedIn
Facebook
Admin
Last Update
Apr 7, 2025
Verified by
Sharon Shapira
Claimed
Yes
Missing
markets, not claimed
Team (5)
Yotam Levin
President of Innovation
Daniel Levitats
CEO
Shuki Yeshurun
Founder
Founder
Efrat Kochba
Medical Director
Yoav Hamisha
Director Of R&D and Operations
Internal
Created by
Raz Zohar (raz@platterz.ca)
Created
2014-09-09T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)